These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
610 related articles for article (PubMed ID: 24211638)
1. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors. Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors. Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208 [TBL] [Abstract][Full Text] [Related]
3. Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors. Alipour M; Khoobi M; Foroumadi A; Nadri H; Moradi A; Sakhteman A; Ghandi M; Shafiee A Bioorg Med Chem; 2012 Dec; 20(24):7214-22. PubMed ID: 23140986 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase. Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase. Rodríguez-Franco MI; Fernández-Bachiller MI; Pérez C; Castro A; Martínez A Bioorg Med Chem; 2005 Dec; 13(24):6795-802. PubMed ID: 16183292 [TBL] [Abstract][Full Text] [Related]
6. Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant. de Souza GA; da Silva SJ; Del Cistia CN; Pitasse-Santos P; Pires LO; Passos YM; Cordeiro Y; Cardoso CM; Castro RN; Sant'Anna CMR; Kümmerle AE J Enzyme Inhib Med Chem; 2019 Dec; 34(1):631-637. PubMed ID: 30727776 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase. Catto M; Pisani L; Leonetti F; Nicolotti O; Pesce P; Stefanachi A; Cellamare S; Carotti A Bioorg Med Chem; 2013 Jan; 21(1):146-52. PubMed ID: 23199476 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase. Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949 [TBL] [Abstract][Full Text] [Related]
11. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies. Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, docking study and biological evaluation of some novel tetrahydrochromeno [3',4':5,6]pyrano[2,3-b]quinolin-6(7H)-one derivatives against acetyl- and butyrylcholinesterase. Khoobi M; Alipour M; Moradi A; Sakhteman A; Nadri H; Razavi SF; Ghandi M; Foroumadi A; Shafiee A Eur J Med Chem; 2013 Oct; 68():291-300. PubMed ID: 23988412 [TBL] [Abstract][Full Text] [Related]
13. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors. Więckowska A; Bajda M; Guzior N; Malawska B Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives. Alipour M; Khoobi M; Moradi A; Nadri H; Homayouni Moghadam F; Emami S; Hasanpour Z; Foroumadi A; Shafiee A Eur J Med Chem; 2014 Jul; 82():536-44. PubMed ID: 24941128 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease. Xie SS; Wang XB; Li JY; Yang L; Kong LY Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer Agents. Tehrani MB; Rezaei Z; Asadi M; Behnammanesh H; Nadri H; Afsharirad F; Moradi A; Larijani B; Mohammadi-Khanaposhtani M; Mahdavi M Chem Biodivers; 2019 Jul; 16(7):e1900144. PubMed ID: 31155827 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives. Kurt BZ; Gazioglu I; Sonmez F; Kucukislamoglu M Bioorg Chem; 2015 Apr; 59():80-90. PubMed ID: 25706320 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors. Raza R; Saeed A; Arif M; Mahmood S; Muddassar M; Raza A; Iqbal J Chem Biol Drug Des; 2012 Oct; 80(4):605-15. PubMed ID: 22726458 [TBL] [Abstract][Full Text] [Related]